Form C received from Mr. Jay Arvind Bhanushali, Promoters Immediate Relative for the acquisition of Equity Shares from the market from May 26, 2025 to May 28, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Jay Arvind Bhanushali, an immediate relative of a Promoter of Aspira Pathlab & Diagnostics, bought 4,129 equity shares from the open market on BSE over three trading sessions from May 26 to May 28, 2025, for a total consideration of approximately ₹2.23 lakh. Following these purchases, his holding in the company increased slightly from 22,84,488 shares (2.22%) to 2,32,577 shares (2.26%). The disclosure was made under SEBI Insider Trading Regulations as a continual disclosure by a designated person's immediate relative.
This is a small insider buy by a member of the promoter group, signalling mild confidence from insiders, though the transaction size (~₹2.23 lakh) and stake increase (0.04%) are too modest to materially influence the stock price or shareholder sentiment.